U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07160738) titled 'A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060' on Aug. 29.
Brief Summary: The purpose of the study is to see and learn the effect of multiple doses of a strong CYP3A4 inhibitor and a potent UGT2B7 inhibitor on the PK of PF-07220060.
Study Start Date: Sept. 09
Study Type: INTERVENTIONAL
Condition:
Healthy Adults
Intervention:
DRUG: PF-07220060
Tablet given orally
DRUG: Itraconazole
Capsule given orally
DRUG: Probenecid
Tablet given orally
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Pfizer
Published by HT Digital Content Services with permi...